Page 14 - Dexcom Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Market Analysis Forecasts Substantial Growth for Global

Dublin, May 03, 2024 (GLOBE NEWSWIRE) The

United statesAsia pacificInsulet corporationMedtronic incBeta bionics incTandem diabetes care incDexcom incBigfoot biomedical incRoche ltdDrug associationArtificial pancreas device systems market reportDevice typeTreatment typeNorth americaLatin americaMiddle east

DexCom, Inc (NASDAQ:DXCM) Holdings Lowered by Fisher Asset Management LLC

Fisher Asset Management LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 991,519 shares of the medical device company’s stock after selling 20,103 shares during the quarter. Fisher Asset Management […]

United statesJacob steven leachMichael jon brownRaymond jamesWestfield capital management coCanaccord genuity groupTimessquare capital managementSands capital managementWinslow capital managementDexcom incRoyal bankExchange commissionFisher asset managementSecurities exchange commissionFree reportAsset management

DexCom (DXCM) – Investment Analysts Weekly Ratings Updates

DexCom (NASDAQ: DXCM) recently received a number of ratings updates from brokerages and research firms: 5/1/2024 – DexCom was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 4/26/2024 – DexCom had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a “strong-buy” rating […]

United kingdomUnited statesSouth gloucestershireMatthew vincent dolanRaymond jamesJeremem sylvainCanaccord genuity group incFintrust capital advisorsNews ratings for dexcom inc dailyCitigroup incKingswood wealth advisorsDexcom incCommonwealth equity servicesCambridge investment research advisors incSecurities exchange commissionValeo financial advisors

DexCom, Inc , v Abbott Diabetes Care, Inc : Federal Circuit Finds Forum Selection Clause Does Not Bar IPR Proceedings Based on Contract Interpretation | Haug Partners LLP

DexCom, Inc , v Abbott Diabetes Care, Inc : Federal Circuit Finds Forum Selection Clause Does Not Bar IPR Proceedings Based on Contract Interpretation | Haug Partners LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

United statesLos angeles cntyDexcom incUs courtAbbott diabetes care sales corpSarepta therapeutics incNippon shinyaku coAbbott diabetes care incUs district courtDiabetes careFederal circuitAbbott diabetes careAbbott diabetes care salesCovenant periodLicensed patentsWestern district

UVA study confirms AI provides efficiency when added to artificial pancreas regulating diabetes

UVA study confirms AI provides efficiency when added to artificial pancreas regulating diabetes
augustafreepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from augustafreepress.com Daily Mail and Mail on Sunday newspapers.

Boris kovatchevDiabetes technology therapeuticsTranslational sciencesNational centerDiabetes technologyDiane manning institute of biotechnologyDexcom incFontaine research parkDrug administrationNet artificial pancreasTandem diabetes careDiane manning instituteFontaine researchNational institutesNational instituteKidney diseases